(Q39448704)

12 September 2017

title

Can climacteric women self-adjust therapeutic estrogen doses using symptoms as markers? (English)

1 reference

12 September 2017

Vihtamäki T

1

1 reference

12 September 2017

Tuimala R

series ordinal

2

1 reference

12 September 2017

publication date

1 January 1998

1 reference

12 September 2017

1 reference

12 September 2017

volume

28

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

199-203

1 reference

Estrogen replacement therapy: indications and complications

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2897%2900083-2

7 January 2021

Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2897%2900083-2

7 January 2021

17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2897%2900083-2

7 January 2021

International consensus conference on postmenopausal hormone therapy and the cardiovascular system.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2897%2900083-2

7 January 2021

Determinants of coronary artery reactivity in premenopausal female cynomolgus monkeys with diet-induced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2897%2900083-2

7 January 2021

Treatment of hot flashes with transdermal estradiol administration

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2897%2900083-2

7 January 2021

Treatment of postmenopausal osteoporosis with transdermal estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2897%2900083-2

7 January 2021

Estrogen replacement in postmenopausal women: are we currently overdosing our patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2897%2900083-2

7 January 2021

Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2897%2900083-2

7 January 2021

10.1016/S0378-5122(97)00083-2

Identifiers

DOI

1 reference

release_pvomkpagqzfa7muo7ft2aj5ove

12 September 2017

Fatcat ID

0 references

1 reference